Children's Health Defense By
The U.S. Food and Drug Administration (FDA) had the opportunity to improve COVID-19 vaccine labeling — but according to a team of medical and public health experts, the agency refused to make the changes.
In an op-ed published last week in The Hill, Peter Doshi, Ph.D., Linda Wastila, Ph.D., and Kim Witczak wrote that the FDA rejected their petition to make changes to FDA-approved labels for the Pfizer and Moderna COVID-19 vaccines, even though the labels, they said, are “obsolete, misleading and out of touch with regulators elsewhere.”
The trio were among a team of nine experts from the Coalition Advocating for Adequately Labeled Medicines (CAALM) who submitted a citizen petition to the FDA on Jan. 31…
